Piramal Pharma Solutions
Jennifer Kolucki is a seasoned professional in analytical development and business management, currently serving as a Business Development Manager at Piramal Pharma Solutions since January 2024. Previously, Jennifer held the position of Associate Director of Analytical Development at Sage Therapeutics from January 2021 to September 2023, where responsibilities included managing analytical activities at CMOs and CROs to support Phase 2 through process validation efforts, as well as leading analytical reviews for NDA submissions of ZurzuvaeTM. Prior roles include Associate Director and Head of Analytical Development at Catabasis Pharmaceuticals, where management of CROs and CMOs for method development and validation was key, and various positions at Chemic Laboratories, culminating in the role of Analytical Chemist II. Jennifer holds a Bachelor of Science degree in Chemistry from Boston College, earned between 2001 and 2005.
This person is not in any offices
Piramal Pharma Solutions
3 followers
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.